Ablation Device Treats Heavy Menstrual Bleeding
|
By HospiMedica International staff writers Posted on 06 Sep 2015 |

Image: The Minerva Surgical Endometrial Ablation System (Photo courtesy of Minerva Surgical).
A new endometrial ablation system treats menorrhagia in premenopausal women due to benign causes, and for whom childbearing is complete.
The Minerva Surgical Endometrial Ablation System uses three separate ablation mechanisms to provide a safer and more effective means of treating excessive menstrual bleeding. The system is based on an impedance controlled treatment cycle specific to individual patient conditions. The first ablation step uses bipolar radiofrequency (RF) energy to ablate the endometrium. The second step uses the high voltage RF electrical current to ionize fully contained and circulated argon gas within a plasma formation array (PFA) sealed silicone membrane.
When the stretchable silicone membrane is deployed it conforms to the uterus; once energized, the argon gas is ionized, turning it in to a stream of plasma which heats the interior surface of the silicone membrane. The thermal energy is then conducted uniformly to the tissue in contact with the membrane. In the third step, released intra-cavitary fluids fills the gaps missed in the first two steps and further ablate remaining endometrial tissue. The system integration results in a faster procedure time and improved tissue contact.
Other features of the system include easy insertion, seating, and a non-stick atraumatic removal due to the lubricous nature of the silicone membrane array; a patented uterine integrity test (UIT) that automatically checks the integrity of the uterine cavity including the array membrane; and a cervical sealing balloon that positively seals the cervix canal near the internal os. The Endometrial Ablation System is a product of Minerva Surgical (Redwood City, CA, USA), and has been approved by the US Food and Drug Administration (FDA).
Menorrhagia, described as heavy and prolonged menstrual bleeding which disrupts a woman's normal activities, is one of the most common complaints in gynecology. Bleeding generally lasts for more than a week, requiring women to change their pad or tampon every two hours or less. Women with menorrhagia may also pass large blood clots and experience anemia due to the volume of blood loss. Constant lower abdominal and pelvic pain, tiredness, fatigue, and shortness of breath due to the heavy bleeding are also common.
Related Links:
Minerva Surgical
Minerva video
The Minerva Surgical Endometrial Ablation System uses three separate ablation mechanisms to provide a safer and more effective means of treating excessive menstrual bleeding. The system is based on an impedance controlled treatment cycle specific to individual patient conditions. The first ablation step uses bipolar radiofrequency (RF) energy to ablate the endometrium. The second step uses the high voltage RF electrical current to ionize fully contained and circulated argon gas within a plasma formation array (PFA) sealed silicone membrane.
When the stretchable silicone membrane is deployed it conforms to the uterus; once energized, the argon gas is ionized, turning it in to a stream of plasma which heats the interior surface of the silicone membrane. The thermal energy is then conducted uniformly to the tissue in contact with the membrane. In the third step, released intra-cavitary fluids fills the gaps missed in the first two steps and further ablate remaining endometrial tissue. The system integration results in a faster procedure time and improved tissue contact.
Other features of the system include easy insertion, seating, and a non-stick atraumatic removal due to the lubricous nature of the silicone membrane array; a patented uterine integrity test (UIT) that automatically checks the integrity of the uterine cavity including the array membrane; and a cervical sealing balloon that positively seals the cervix canal near the internal os. The Endometrial Ablation System is a product of Minerva Surgical (Redwood City, CA, USA), and has been approved by the US Food and Drug Administration (FDA).
Menorrhagia, described as heavy and prolonged menstrual bleeding which disrupts a woman's normal activities, is one of the most common complaints in gynecology. Bleeding generally lasts for more than a week, requiring women to change their pad or tampon every two hours or less. Women with menorrhagia may also pass large blood clots and experience anemia due to the volume of blood loss. Constant lower abdominal and pelvic pain, tiredness, fatigue, and shortness of breath due to the heavy bleeding are also common.
Related Links:
Minerva Surgical
Minerva video
Latest Surgical Techniques News
- Brain Implant Records Neural Signals and Delivers Precise Medication
- AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries
- Neural Device Regrows Surrounding Skull After Brain Implantation
- Surgical Innovation Cuts Ovarian Cancer Risk by 80%
- New Imaging Combo Offers Hope for High-Risk Heart Patients
- New Classification System Brings Clarity to Brain Tumor Surgery Decisions
- Boengineered Tissue Offers New Hope for Secondary Lymphedema Treatment
- Dual-Energy Catheter Brings New Flexibility to AFib Ablation
- 3D Bioprinting Pushes Boundaries in Quest for Custom Livers
- New AI Approach to Improve Surgical Imaging
- First-Of-Its-Kind Probe Monitors Fetal Health in Utero During Surgery
- Ultrasound Device Offers Non-Invasive Treatment for Kidney Stones
- Light-Activated Tissue Adhesive Patch Achieves Rapid and Watertight Neurosurgical Sealing
- Minimally Invasive Coronary Artery Bypass Method Offers Safer Alternative to Open-Heart Surgery
- Injectable Breast ‘Implant’ Offers Alternative to Traditional Surgeries
- AI Detects Stomach Cancer Risk from Upper Endoscopic Images
Channels
Artificial Intelligence
view channelCritical Care
view channel
Aptamers Enable Real-Time Biomarker Tracking Without Blood Draws
Continuous monitoring of biomarkers is critical for early disease detection, treatment evaluation, and personalized health management. Yet most clinical tests still rely on invasive, single-point blood... Read more
Specialized Dressing with Sensor Monitors pH Levels in Chronic Wounds
Any wound has the potential to become chronic, but the risk is significantly higher in individuals with certain medical conditions. Once a wound becomes chronic, healing slows, complications increase,... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







